Alasdair Scott of Imperial College, London, discusses our Special Issue "The microbiome - a novel paradigm in oncology research".

This special issue explores the rapidly evolving field of the microbiome and cancer.  It consists of six articles from members of the International Cancer Microbiome Consortium which take readers through the technology and “omics” sciences underpinning microbiome research, including how the microbiome may cause cancer and the interaction of the microbiome with chemotherapeutics.

The issue provides a solid introduction and broad overview of microbiome-oncology research for clinicians and scientists who may be less familiar with this novel field.